Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Scutellaria baicalensis extract and baicalin may help prevent hair loss.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Male rats have androgen receptors in their liver, which are different from proteins that bind estrogen.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Certain Dibenzo derivatives may help treat prostate cancer.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Combining RU58841 and minoxidil significantly increases hair growth.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Longer CAG repeats in gene linked to more severe hair loss in females.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.